Abstract 12454: Prognostic Value of Computational Pressure-Flow Dynamics Derived Fractional Flow Reserve in Non-Culprit Vessels Among Patients Presenting With Acute Coronary Syndrome and Multivessel Disease
Ka Lam Calvin Leung,Lok Yee Lam,Kwan Yu LI,Shuk Yin Yu,Mei Zhen Wu,Qing Wen Ren,Pui Fai Wong,Yi Kei Tse,Si Yeung Yu,Hang Long Li,Yundi Feng,Yunlong Huo,Hung Fat Tse,Kai Hang Yiu,Ka Lam Calvin LeungLok Yee LamKwan Yu LIShuk Yin YuMei Zhen WuQing Wen RenPui Fai WongYi Kei TseSi Yeung YuHang Long LiYundi FengYunlong HuoHung Fat TseKai Hang YiuDept of Medicine,The Univ of Hong Kong,Hong KongDept of Medicine,Queen Mary Hosp,Hong KongPKU-HKUST Shenzhen-Hongkong Inst,Shenzhen,ChinaUniv of Hong Kong,Hong KongThe Univ of Hong Kong,Hong Kong
DOI: https://doi.org/10.1161/circ.144.suppl_1.12454
IF: 37.8
2021-11-10
Circulation
Abstract:Circulation, Volume 144, Issue Suppl_1, Page A12454-A12454, November 16, 2021. Introduction:Computational pressure-flow dynamics derived fractional flow reserve (caFFR) is a novel index developed to assess the severity of myocardial ischemia in patients with coronary artery stenoses, without the requirement of invasive pressure wire and hyperemic stimulus needed in fractional flow reserve (FFR) measurement. In patients presenting with acute coronary syndrome (ACS), the non-culprit vessels are often diseased concomitantly, and the ischemia status of such vessels may affect clinical outcomes. In this study, we aimed to evaluate the prognostic value of caFFR in non-culprit vessels among ACS patients with multivessel disease.Methods:Patients presented with ACS and at least two vessels having ≥50% diameter stenosis were included, and the culprit vessel was identified for each patient. Analyses of caFFR were performed for the two non-culprit vessels of every patient. Based on the threshold of 0.8 adopted from FFR studies, patients were stratified into ischemic group if any non-culprit vessel caFFR was ≤0.8, and into non-ischemic group if none of the non-culprit vessels had caFFR≤0.8. The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of all-cause mortality, non-fatal myocardial infarction, and any subsequent revascularization.Results:A total of 293 patients (mean age 65.3±13.2, male 77.5%) were included, with 113 (38.6%) presented with STEMI, 119 (40.6%) presented with NSTEMI, and 41 (14.0%) presented with unstable angina. The ischemic group patients (n=176) had more obstructive lesions compared to non-ischemic group patients (n=117) (3.8±1.5 vs. 3.2±1.1, p<0.001). The MACE event rate at 3 years was higher in ischemic group compared to non-ischemic group (28.4% vs. 15.4%; adjusted hazard ratio, 1.92; 95% confidence interval, 1.10-3.36; p=0.023).Conclusions:In ACS patients with multivessel disease, myocardial ischemia in non-culprit vessels assessed by caFFR was associated with adverse clinical outcomes in terms of MACE.
cardiac & cardiovascular systems,peripheral vascular disease